Li Ruojing, Zhao Yeying, Zheng Zhiqiang, Liu Yangyang, Song Shurui, Song Lei, Ren Jianan, Dong Jing, Wang Peige
Department of Emergency Surgery, The Affiliated Hospital of Qingdao University 16 Jiangsu Road Qingdao 266000 China
Department of General Surgery, The Affiliated General Hospital of Nanjing Military Region 305 Zhongshan East Road Nanjing 210016 China
RSC Adv. 2023 Mar 3;13(11):7153-7167. doi: 10.1039/d2ra07037e. eCollection 2023 Mar 1.
bioprinting provides a reliable solution to the problem of tissue culture and vascularization by printing tissue directly at the site of injury or defect and maturing the printed tissue using the natural cell microenvironment . As an emerging field, bioprinting is based on computer-assisted scanning results of the defect site and is able to print cells directly at this site with biomaterials, bioactive factors, and other materials without the need to transfer prefabricated grafts as with traditional 3D bioprinting methods, and the resulting grafts can accurately adapt to the target defect site. However, one of the important reasons hindering the development of bioprinting is the absence of suitable bioinks. In this review, we will summarize bioinks developed in recent years that can adapt to printing scenarios at the defect site, considering three aspects: the design strategy of bioink, the selection of commonly used biomaterials, and the application of bioprinting to different treatment scenarios.
生物打印通过在损伤或缺损部位直接打印组织,并利用天然细胞微环境使打印组织成熟,为组织培养和血管化问题提供了可靠的解决方案。作为一个新兴领域,生物打印基于缺损部位的计算机辅助扫描结果,能够在该部位直接将细胞与生物材料、生物活性因子及其他材料一起打印,无需像传统3D生物打印方法那样转移预制移植物,且所得移植物能够准确适应目标缺损部位。然而,阻碍生物打印发展的一个重要原因是缺乏合适的生物墨水。在本综述中,我们将从生物墨水的设计策略、常用生物材料的选择以及生物打印在不同治疗场景中的应用这三个方面,总结近年来开发的能够适应缺损部位打印场景的生物墨水。